In BMC nephrology ; h5-index 39.0
BACKGROUND : Lupus nephropathy (LN) occurs in approximately 50% of patients with systemic lupus erythematosus (SLE), and 20% of them will eventually progress into end-stage renal disease (ESRD). A clinical tool predicting remission of proteinuria might be of utmost importance. In our work, we focused on predicting the chance of complete remission achievement in LN patients, using artificial intelligence models, especially an artificial neural network, called the multi-layer perceptron.
METHODS : It was a single centre retrospective study, including 58 individuals, with diagnosed systemic lupus erythematous and biopsy proven lupus nephritis. Patients were assigned into the study cohort, between 1st January 2010 and 31st December 2020, and eventually randomly allocated either to the training set (N = 46) or testing set (N = 12). The end point was remission achievement. We have selected an array of variables, subsequently reduced to the optimal minimum set, providing the best performance.
RESULTS : We have obtained satisfactory results creating predictive models allowing to assess, with accuracy of 91.67%, a chance of achieving a complete remission, with a high discriminant ability (AUROC 0.9375).
CONCLUSION : Our solution allows an accurate assessment of complete remission achievement and monitoring of patients from the group with a lower probability of complete remission. The obtained models are scalable and can be improved by introducing new patient records.
Stojanowski Jakub, Konieczny Andrzej, Rydzyńska Klaudia, Kasenberg Izabela, Mikołajczak Aleksandra, Gołębiowski Tomasz, Krajewska Magdalena, Kusztal Mariusz
2022-Nov-28
Artificial intelligence, End-stage renal disease, Lupus nephritis, Machine learning, Proteinuria, Systemic lupus erythematosus
